Growth Metrics

Replimune (REPL) Cash & Current Investments (2018 - 2025)

Replimune has reported Cash & Current Investments over the past 8 years, most recently at $269.1 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $269.1 million for Q4 2025, down 49.84% from a year ago — trailing twelve months through Dec 2025 was $269.1 million (down 49.84% YoY), and the annual figure for FY2025 was $483.8 million, up 15.01%.
  • Cash & Current Investments reached $269.1 million in Q4 2025 per REPL's latest filing, down from $323.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $616.4 million in Q4 2022 and bottomed at $269.1 million in Q4 2025.
  • Median Cash & Current Investments over the past 5 years was $447.1 million (2021), compared with a mean of $446.9 million.
  • The largest annual shift saw Cash & Current Investments soared 226.76% in 2021 before it tumbled 49.84% in 2025.
  • Over 5 years, Cash & Current Investments stood at $420.2 million in 2021, then skyrocketed by 46.7% to $616.4 million in 2022, then decreased by 24.34% to $466.4 million in 2023, then increased by 15.05% to $536.5 million in 2024, then crashed by 49.84% to $269.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for REPL at $269.1 million in Q4 2025, $323.6 million in Q3 2025, and $403.3 million in Q2 2025.